FDA Approves New Merck Drug

Last Updated: Wednesday, March 27, 2024 9:39 AM | Bobby Raines

Morning News Leader

Merck (MRK) said the FDA approved Winrevair, a treatment for adults with pulmonary arterial hypertension.

InvestorsKeyhole Trade Alert

Share this article:

Related Companies

You May Also Like

Related Articles

Unusual Options Activity: Call Buying on Guardant Health

Unusual Options Activity: Call Buying on Sanofi

Inuitive Surgical Beats, Raises

Danaher Corp (DHR) Upgraded to Buy from Hold

Unusual Options Activity: Call Buying on Annovis Bio

United Health Beats on Top and Bottom Lines

Related Companies